OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
PAR:OSE
Watchlist
Price: 6.27 EUR -2.64% Market Closed
Market Cap: 137.6m EUR

Operating Margin
OSE Immunotherapeutics SA

64.6%
Current
-283%
Average
-6.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
64.6%
=
Operating Profit
53.9m
/
Revenue
83.4m

Operating Margin Across Competitors

OSE Immunotherapeutics SA
Glance View

Market Cap
136.5m EUR
Industry
Biotechnology

OSE Immunotherapeutics SA develops immunotherapy products for cancer and auto-immune disease. The company is headquartered in Nantes, Pays De La Loire and currently employs 61 full-time employees. The company went IPO on 2015-03-30. The company develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The firm's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. The company provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.

OSE Intrinsic Value
7.93 EUR
Undervaluation 21%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
64.6%
=
Operating Profit
53.9m
/
Revenue
83.4m
What is the Operating Margin of OSE Immunotherapeutics SA?

Based on OSE Immunotherapeutics SA's most recent financial statements, the company has Operating Margin of 64.6%.

Back to Top